Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunotherapeutic Potential of m6A-Modifiers and MicroRNAs in Controlling Acute Myeloid Leukaemia
Sunil Kumar, Ravinder Nagpal, Amit Kumar, et al.
Biomedicines (2021) Vol. 9, Iss. 6, pp. 690-690
Open Access | Times Cited: 22

Showing 22 citing articles:

Functions, mechanisms, and therapeutic implications of METTL14 in human cancer
Qian Guan, Huiran Lin, Lei Miao, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 78
Epigenetic modification of m6A regulator proteins in cancer
Yumin Wang, Yan Wang, Harsh Patel, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 71
Small molecule inhibitors targeting m6A regulators
Guotai Feng, Yongya Wu, Yuan Hu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 10
m5C regulator‐mediated methylation modification patterns and tumor microenvironment infiltration characteristics in acute myeloid leukemia
Qiang Wen, ShouJun Wang, Lili Hong, et al.
Immunity Inflammation and Disease (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 5
Alternative splicing of HOXB-AS3 underlie the promoting effect of nuclear m6A reader YTHDC1 on the self-renewal of leukemic stem cells in acute myeloid leukemia
Chuan Wu, Jieke Cui, Yankun Huo, et al.
International Journal of Biological Macromolecules (2023) Vol. 237, pp. 123990-123990
Closed Access | Times Cited: 12
N6-Methyladenosine RNA Modification in the Tumor Immune Microenvironment: Novel Implications for Immunotherapy
Liting Guo, Yang Hui, Chenfei Zhou, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 31
ALKBH5 Promotes Multiple Myeloma Tumorigenicity through inducing m6A-demethylation of SAV1 mRNA and Myeloma Stem Cell Phenotype
Tingting Yu, Lan Yao, Hua Yin, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 6, pp. 2235-2248
Open Access | Times Cited: 19
Comprehensive analysis of m6A methylome alterations after azacytidine plus venetoclax treatment for acute myeloid leukemia by nanopore sequencing
Zaifeng Zhang, Lili Zhang, Jiangtao Li, et al.
Computational and Structural Biotechnology Journal (2024) Vol. 23, pp. 1144-1153
Open Access | Times Cited: 3
Biological Aspects of Inflamm-Aging in Childhood Cancer Survivors
Francesca Rossi, Alessandra Di Paola, Elvira Pota, et al.
Cancers (2021) Vol. 13, Iss. 19, pp. 4933-4933
Open Access | Times Cited: 25
YTHDF1’s Regulatory Involvement in Breast Cancer Prognosis, Immunity, and the ceRNA Network
Wenting Luo, Youjia Zhou, Jiayang Wang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1879-1879
Open Access | Times Cited: 2
Immunotherapy as a Turning Point in the Treatment of Acute Myeloid Leukemia
Anna Aureli, Beatrice Marziani, Tommaso Sconocchia, et al.
Cancers (2021) Vol. 13, Iss. 24, pp. 6246-6246
Open Access | Times Cited: 18
Interplay Between m6A RNA Methylation and Regulation of Metabolism in Cancer
Youchaou Mobet, Xiaoyi Liu, Tao Liu, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 12
The Role of N6-Methyladenosine in the Promotion of Hepatoblastoma: A Critical Review
Finn Morgan Auld, Consolato Sergi, Roger Leng, et al.
Cells (2022) Vol. 11, Iss. 9, pp. 1516-1516
Open Access | Times Cited: 9
RNA Modification in Inflammatory Bowel Diseases
Mika Nakayama, Yuki Ozato, Yoshiko Tsuji, et al.
Biomedicines (2022) Vol. 10, Iss. 7, pp. 1695-1695
Open Access | Times Cited: 9
FTO plays a crucial role in gastrointestinal cancer and may be a target for immunotherapy: an updated review
Xiangqing Ren, Xiaolong Tang, Tian Huang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 4
Dynamic m6A-ncRNAs association and their impact on cancer pathogenesis, immune regulation and therapeutic response
Yuanliang Yan, Jinwu Peng, Qiuju Liang, et al.
Genes & Diseases (2021) Vol. 10, Iss. 1, pp. 135-150
Open Access | Times Cited: 9
m6A RNA methylation regulator-based signature for prognostic prediction and its potential immunological role in uterine corpus endometrial carcinoma
Fang Fang, Peipei Wang, Haoyu Huang, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Epitranscriptomic Approach: To Improve the Efficacy of ICB Therapy by Co-Targeting Intracellular Checkpoint CISH
Sunil Kumar, Parth Sarthi, Indra Mani, et al.
Cells (2021) Vol. 10, Iss. 9, pp. 2250-2250
Open Access | Times Cited: 8
Identification of Protein Biomarker Signatures for Acute Myeloid Leukemia (AML) Using Both Nontargeted and Targeted Approaches
Paul Dowling, Ciara Tierney, Katie Dunphy, et al.
Proteomes (2021) Vol. 9, Iss. 4, pp. 42-42
Open Access | Times Cited: 8
[Study on the Role and Mechanism of METTL3 Mediating the Up-regulation of 
m6A Modified Long Non-coding RNA THAP7-AS1 in Promoting the Occurrence of 
Lung Cancer].
Yu Zhang, Yanhong Wang, Mei Liu
PubMed (2024) Vol. 26, Iss. 12, pp. 919-933
Closed Access
One Stone, Two Birds: N6-Methyladenosine RNA Modification in Leukemia Stem Cells and the Tumor Immune Microenvironment in Acute Myeloid Leukemia
Xianfeng Ouyang, Yuping Gong
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 3
Epitranscriptomic Approach: To Improve the Efficacy of ICB Therapy by Co-targeting Intracellular Checkpoint CISH
Sunil Kumar, Parth Sarthi, Indra Mani, et al.
(2021)
Open Access | Times Cited: 3
Page 1

Scroll to top